Literature DB >> 24709390

Overview of vertebrate animal models of fungal infection.

Tobias M Hohl1.   

Abstract

Fungi represent emerging infectious threats to human populations worldwide. Mice and other laboratory animals have proved invaluable in modeling clinical syndromes associated with superficial and life-threatening invasive mycoses. This review outlines salient features of common vertebrate animal model systems to study fungal pathogenesis, host antifungal immune responses, and antifungal compounds.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Animal model; Fungus; Immune response; Mouse; Pathogenesis; Yeast

Mesh：

Year:  2014        PMID： 24709390      PMCID： PMC4163114          DOI： 10.1016/j.jim.2014.03.022

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN： 0022-1759            Impact factor:   2.303


  151 in total

Review 1.  Conventional or molecular measurement of Aspergillus load.

Authors:  K V Clemons; D A Stevens
Journal:  Med Mycol       Date:  2008-07-24       Impact factor: 4.076

Review 2.  Recent advances in the treatment of life-threatening, invasive fungal infections.

Authors:  Richard H Drew; Mary L Townsend; Melanie W Pound; Steven W Johnson; John R Perfect
Journal:  Expert Opin Pharmacother       Date:  2013-09-19       Impact factor: 3.889

3.  Antifungal efficacy of caspofungin (MK-0991) in experimental pulmonary aspergillosis in persistently neutropenic rabbits: pharmacokinetics, drug disposition, and relationship to galactomannan antigenemia.

Authors:  Ruta Petraitiene; Vidmantas Petraitis; Andreas H Groll; Tin Sein; Robert L Schaufele; Andrea Francesconi; John Bacher; Nilo A Avila; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

4.  Non-invasive imaging of disseminated candidiasis in zebrafish larvae.

Authors:  Kimberly M Brothers; Robert T Wheeler
Journal:  J Vis Exp       Date:  2012-07-30       Impact factor: 1.355

Review 5.  Experimental oral candidiasis in animal models.

Authors:  Y H Samaranayake; L P Samaranayake
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

6.  Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry.

Authors:  William J Steinbach; Kieren A Marr; Elias J Anaissie; Nkechi Azie; Shun-Ping Quan; Herwig-Ulf Meier-Kriesche; Senu Apewokin; David L Horn
Journal:  J Infect       Date:  2012-08-13       Impact factor: 6.072

7.  A nebulized intra-tracheal rat model of invasive pulmonary aspergillosis.

Authors:  Guillaume Desoubeaux; Jacques Chandenier
Journal:  Methods Mol Biol       Date:  2012

8.  Distinct roles for Dectin-1 and TLR4 in the pathogenesis of Aspergillus fumigatus keratitis.

Authors:  Sixto M Leal; Susan Cowden; Yen-Cheng Hsia; Mahmoud A Ghannoum; Michelle Momany; Eric Pearlman
Journal:  PLoS Pathog       Date:  2010-07-01       Impact factor: 6.823

9.  An alternative animal model for comparison of treatments for cryptococcal meningitis.

Authors:  L K Najvar; R Bocanegra; J R Graybill
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

10.  Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease.

Authors:  Luigina Romani; Francesca Fallarino; Antonella De Luca; Claudia Montagnoli; Carmen D'Angelo; Teresa Zelante; Carmine Vacca; Francesco Bistoni; Maria C Fioretti; Ursula Grohmann; Brahm H Segal; Paolo Puccetti
Journal:  Nature       Date:  2008-01-10       Impact factor: 49.962
View more
  23 in total

Review 1.  Immune responses to invasive aspergillosis: new understanding and therapeutic opportunities.

Authors:  Tobias M Hohl
Journal:  Curr Opin Infect Dis       Date:  2017-08       Impact factor: 4.915

2.  Card9- and MyD88-Mediated Gamma Interferon and Nitric Oxide Production Is Essential for Resistance to Subcutaneous Coccidioides posadasii Infection.

Authors:  Chiung-Yu Hung; Natalia Castro-Lopez; Garry T Cole
Journal:  Infect Immun       Date:  2016-03-24       Impact factor: 3.441

Review 3.  Animal Models of Aspergillosis.

Authors:  Guillaume Desoubeaux; Carolyn Cray
Journal:  Comp Med       Date:  2018-04-02       Impact factor: 0.982

Review 4.  Menacing Mold: Recent Advances in Aspergillus Pathogenesis and Host Defense.

Authors:  Benjamin Y Tischler; Tobias M Hohl
Journal:  J Mol Biol       Date:  2019-04-04       Impact factor: 5.469

Review 5.  Essential Oils in Respiratory Mycosis: A Review.

Authors:  Mónica Zuzarte; Lígia Salgueiro
Journal:  Molecules       Date:  2022-06-28       Impact factor: 4.927

6.  The Added Value of Longitudinal Imaging for Preclinical In Vivo Efficacy Testing of Therapeutic Compounds against Cerebral Cryptococcosis.

Authors:  Greetje Vande Velde; Uwe Himmelreich; Liesbeth Vanherp; Jennifer Poelmans; Amy Hillen; Guilhem Janbon; Matthias Brock; Katrien Lagrou
Journal:  Antimicrob Agents Chemother       Date:  2020-06-23       Impact factor: 5.191

Review 7.  Immunity against fungi.

Authors:  Michail S Lionakis; Iliyan D Iliev; Tobias M Hohl
Journal:  JCI Insight       Date:  2017-06-02

8.  In Vitro and In Vivo Assessment of FK506 Analogs as Novel Antifungal Drug Candidates.

Authors:  Yeonseon Lee; Kyung-Tae Lee; Soo Jung Lee; Ji Yoon Beom; Areum Hwangbo; Jin A Jung; Myoung Chong Song; Young Ji Yoo; Sang Hyeon Kang; Anna F Averette; Joseph Heitman; Yeo Joon Yoon; Eunji Cheong; Yong-Sun Bahn
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

Review 9.  Mouse ENU Mutagenesis to Understand Immunity to Infection: Methods, Selected Examples, and Perspectives.

Authors:  Grégory Caignard; Megan M Eva; Rebekah van Bruggen; Robert Eveleigh; Guillaume Bourque; Danielle Malo; Philippe Gros; Silvia M Vidal
Journal:  Genes (Basel)       Date:  2014-09-29       Impact factor: 4.096

10.  Extrapolating Antifungal Animal Data to Humans - Is it reliable?

Authors:  Victoria M Stevens; Scott W Mueller; Paul M Reynolds; Robert MacLaren; Tyree H Kiser
Journal:  Curr Fungal Infect Rep       Date:  2020-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.